Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Immune Efficiency, Interactions with Therapy and Administration of SARS-CoV-2 Vaccine in Patients with Cancer

ESMO-Immune-Efficeiency-SARS-CoV-2-Vaccine-Webinar-1000x250

Immune Efficiency, Interactions with Therapy and Administration of SARS-CoV-2 Vaccine in Patients with Cancer

The programme is designed to offer expert opinion exchange, provide some considerations on indications and contraindications for vaccines, the development of immune response to vaccines, and the duration of protection, with an emphasis on patients with cancer and on potential problems in developing countries.

Immune Efficiency, Interactions with Therapy and Administration of
SARS-CoV-2 Vaccine in Patients with Cancer

Chair: Ignacio Melero Bermejo
Speakers: Marie von Lilienfeld-Toal, Olivier Mir, Per Ljungman

Watch now*

Watch now on demand ​(Aired live on 9 February 2021 at 17:30 CET)

*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology. 

If you are an ESMO Member or already have a free ESMO Account, you can log in and watch the ESMO Webinar Series using your existing ESMO Account.

Don’t have an ESMO Account?

Please set up a free ESMO Account now to access the ESMO Webinars Series.

Programme 

  • Welcome and Introduction, Prof. Ignacio Melero Bermejo, Division of Immunology and Immunotherapy, Center for Applied Medical Research, University of Navarra, Pamplona, Spain
  • The Ability of Cancer Patients to Generate Immune Responses to Vaccines: Indications and Contraindications, Prof. Marie von Lilienfeld-Toal, Department for Hematology and Medical Oncology, Clinic of Internal Medicine II, University Hospital Jena, Jena, Germany 
  • Potential for Interactions of Antineoplastic Therapies and Vaccines, Dr. Olivier Mir, PhD, MPH, Ambulatory Cancer Care Department, Gustave Roussy Cancer Institute, University Paris Saclay, Villejuif, France
  • SARS-CoV-2 Vaccine Timing of Administration and Duration of Protection:  Impact on Oncology Practice, Prof. (em) Per Ljungman, Division of Hematology, Dept. of Medicine Huddinge, Karolinska Institutet & Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden
  • Q&A
  • Closing Remarks, Prof. Ignacio Melero Bermejo, Division of Immunology and Immunotherapy, Center for Applied Medical Research, University of Navarra, Pamplona, Spain

Learning objectives: 

  • To elaborate the ability of cancer patients to generate immune responses to vaccines, indications and contraindications
  • To elaborate potential interactions between anticancer therapies and SARS-CoV-2 vaccines
  • To elaborate different problems related to SARS-CoV-2 vaccines timing of administration and duration of protection with an emphasis on cancer patients and developing countries

Watch now*

Watch now on demand ​(Aired live on 9 February 2021 at 17:30 CET)

*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology. 

If you are an ESMO Member or already have a free ESMO Account, you can log in and watch the ESMO Webinar Series using your existing ESMO Account.

Don’t have an ESMO Account?

Please set up a free ESMO Account now to access the ESMO Webinars Series.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings